Cherng-Chyi Tzeng

468 total citations
16 papers, 401 citations indexed

About

Cherng-Chyi Tzeng is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Cherng-Chyi Tzeng has authored 16 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Toxicology. Recurrent topics in Cherng-Chyi Tzeng's work include Cancer therapeutics and mechanisms (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Synthesis and biological activity (5 papers). Cherng-Chyi Tzeng is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Synthesis and biological activity (5 papers). Cherng-Chyi Tzeng collaborates with scholars based in Taiwan and United States. Cherng-Chyi Tzeng's co-authors include Yeh-Long Chen, Chih-Hua Tseng, Pei‐Jung Lu, Chia-Ning Yang, Hui‐Ling Chen, Chun-Wei Tung, Hao‐Yi Li, Che‐Ming Teng, Tsong‐Long Hwang and Yen‐Hsu Chen and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and Cancer Letters.

In The Last Decade

Cherng-Chyi Tzeng

16 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cherng-Chyi Tzeng Taiwan 10 273 185 64 42 36 16 401
Warren Miller United Kingdom 6 211 0.8× 167 0.9× 56 0.9× 53 1.3× 46 1.3× 7 351
Edward J. Salaski United States 10 176 0.6× 193 1.0× 33 0.5× 91 2.2× 31 0.9× 14 349
Ganesh Bist South Korea 16 290 1.1× 253 1.4× 111 1.7× 66 1.6× 78 2.2× 27 493
Xiao‐Hui Gu China 9 311 1.1× 223 1.2× 39 0.6× 33 0.8× 128 3.6× 13 606
Rammohan R. Yadav India 12 353 1.3× 145 0.8× 51 0.8× 56 1.3× 23 0.6× 13 475
Niggula Praveen Kumar India 16 547 2.0× 196 1.1× 45 0.7× 58 1.4× 29 0.8× 17 643
M. Kashi Reddy India 13 590 2.2× 243 1.3× 55 0.9× 38 0.9× 57 1.6× 19 661
Ali Nakhi India 13 282 1.0× 131 0.7× 17 0.3× 35 0.8× 51 1.4× 17 464
Laurent Gomez United States 13 284 1.0× 239 1.3× 28 0.4× 75 1.8× 27 0.8× 26 459
Dalia H. Soliman Egypt 11 404 1.5× 215 1.2× 52 0.8× 35 0.8× 48 1.3× 21 500

Countries citing papers authored by Cherng-Chyi Tzeng

Since Specialization
Citations

This map shows the geographic impact of Cherng-Chyi Tzeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherng-Chyi Tzeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherng-Chyi Tzeng more than expected).

Fields of papers citing papers by Cherng-Chyi Tzeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherng-Chyi Tzeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherng-Chyi Tzeng. The network helps show where Cherng-Chyi Tzeng may publish in the future.

Co-authorship network of co-authors of Cherng-Chyi Tzeng

This figure shows the co-authorship network connecting the top 25 collaborators of Cherng-Chyi Tzeng. A scholar is included among the top collaborators of Cherng-Chyi Tzeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherng-Chyi Tzeng. Cherng-Chyi Tzeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Miller, Dannah, Cherng-Chyi Tzeng, Evan T. Keller, et al.. (2018). Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer. Cancer Letters. 436. 96–108. 6 indexed citations
2.
Tseng, Chih-Hua, et al.. (2018). Discovery of Pyrazolo[4,3-c]quinolines Derivatives as Potential Anti-Inflammatory Agents through Inhibiting of NO Production. Molecules. 23(5). 1036–1036. 17 indexed citations
3.
Tzeng, Cherng-Chyi, et al.. (2017). A 15‐year‐long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan. Clinical Genetics. 92(2). 217–220. 6 indexed citations
4.
Tseng, Chih-Hua, Chun-Wei Tung, Cherng-Chyi Tzeng, et al.. (2017). Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents. Molecules. 22(6). 1001–1001. 35 indexed citations
5.
Tseng, Chih-Hua, Yu‐Wen Chen, Shyh‐Chyun Yang, et al.. (2015). Discovery of Novel <i>N</i>-alkyl 4-anilinofuro[2,3-<i>b</i>]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers. Anti-Cancer Agents in Medicinal Chemistry. 15(4). 493–500. 3 indexed citations
6.
Tseng, Chih-Hua, Cherng-Chyi Tzeng, Chien‐Chih Chiu, et al.. (2014). Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4. MedChemComm. 5(7). 937–948. 7 indexed citations
7.
Tseng, Chih-Hua, Cherng-Chyi Tzeng, Pei‐Jung Lu, et al.. (2013). Discovery of indeno[1,2- $$c$$ c ]quinoline derivatives as dual topoisomerases I/II inhibitors: Part 3. Molecular Diversity. 17(4). 781–799. 14 indexed citations
8.
Chen, Yu‐Wen, Yeh-Long Chen, Chih-Hua Tseng, et al.. (2011). Discovery of 4-Anilinofuro[2,3-b]quinoline Derivatives as Selective and Orally Active Compounds against Non-Small-Cell Lung Cancers. Journal of Medicinal Chemistry. 54(13). 4446–4461. 35 indexed citations
9.
Tseng, Chih-Hua, Cherng-Chyi Tzeng, Pei‐Jung Lu, et al.. (2010). Synthesis and Antiproliferative Evaluation of Certain Indeno[1,2-c]quinoline Derivatives. Part 2. Journal of Medicinal Chemistry. 53(16). 6164–6179. 71 indexed citations
10.
Tseng, Chih-Hua, Yeh-Long Chen, Pei‐Jung Lu, Chia-Ning Yang, & Cherng-Chyi Tzeng. (2008). Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Bioorganic & Medicinal Chemistry. 16(6). 3153–3162. 108 indexed citations
11.
Lu, Pei‐Jung, et al.. (2005). Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives. Bioorganic & Medicinal Chemistry. 13(21). 6045–6053. 29 indexed citations
12.
Tzeng, Cherng-Chyi, et al.. (2001). An Effective Strategy of Using Molecular Testing to Screen Mentally Retarded Individuals for Fragile X Syndrome. Diagnostic Molecular Pathology. 10(1). 34–40. 6 indexed citations
13.
Tzeng, Cherng-Chyi, et al.. (1999). Synthesis of Tc-D,D-HMPAO and Tc-L,L-HMPAO and their comparison of chemical and biological properties. Bioorganic & Medicinal Chemistry Letters. 9(22). 3199–3202. 4 indexed citations
14.
Chang, Nein‐Chen, et al.. (1998). .ALPHA.-Methylene-.GAMMA.-butyrolactones: Synthesis and Vasorelaxing Activity Assay of Coumarin, Naphthalene, and Quinoline Derivatives.. Chemical and Pharmaceutical Bulletin. 46(6). 962–965. 20 indexed citations
15.
Teng, Che‐Ming, et al.. (1996). Synthesis and Evaluation of Coumarin .ALPHA.-Methylene-.GAMMA.-butyrolactones: A New Class of Platelet Aggregation Inhibitors.. Chemical and Pharmaceutical Bulletin. 44(8). 1591–1595. 19 indexed citations
16.
Tzeng, Cherng-Chyi, et al.. (1993). Synthesis of a new class of uridine phosphorylase inhibitors. Journal of Heterocyclic Chemistry. 30(5). 1399–1404. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Warren Miller Breakdown of academic impact, for papers by Edward J. Salaski Breakdown of academic impact, for papers by Ganesh Bist Breakdown of academic impact, for papers by Xiao‐Hui Gu Breakdown of academic impact, for papers by Rammohan R. Yadav Breakdown of academic impact, for papers by Niggula Praveen Kumar Breakdown of academic impact, for papers by M. Kashi Reddy Breakdown of academic impact, for papers by Ali Nakhi Breakdown of academic impact, for papers by Laurent Gomez Breakdown of academic impact, for papers by Dalia H. Soliman
Rankless by CCL
2026